LT2806873T - Amidinu pakeisto beta-laktamo junginiai, jų gavimas ir jų, kaip antibakterinių agentų, panaudojimas - Google Patents
Amidinu pakeisto beta-laktamo junginiai, jų gavimas ir jų, kaip antibakterinių agentų, panaudojimasInfo
- Publication number
- LT2806873T LT2806873T LTEP13701246.4T LT13701246T LT2806873T LT 2806873 T LT2806873 T LT 2806873T LT 13701246 T LT13701246 T LT 13701246T LT 2806873 T LT2806873 T LT 2806873T
- Authority
- LT
- Lithuania
- Prior art keywords
- preparation
- antibacterial agents
- lactam compounds
- substituted beta
- amidine substituted
- Prior art date
Links
- 150000001409 amidines Chemical group 0.000 title 1
- 239000003242 anti bacterial agent Substances 0.000 title 1
- -1 beta-lactam compounds Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12152279 | 2012-01-24 | ||
| PCT/EP2013/051217 WO2013110643A1 (en) | 2012-01-24 | 2013-01-23 | Amidine substituted beta - lactam compounds, their preparation and use as antibacterial agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT2806873T true LT2806873T (lt) | 2016-10-10 |
Family
ID=47603723
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP13701246.4T LT2806873T (lt) | 2012-01-24 | 2013-01-23 | Amidinu pakeisto beta-laktamo junginiai, jų gavimas ir jų, kaip antibakterinių agentų, panaudojimas |
Country Status (43)
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160326157A1 (en) * | 2014-01-06 | 2016-11-10 | President And Fellows Of Harvard College | Monobactams and methods of their synthesis and use |
| WO2015148379A1 (en) | 2014-03-24 | 2015-10-01 | Novartis Ag | Monobactam organic compounds for the treatment of bacterial infections |
| CN105175335B (zh) * | 2015-08-13 | 2017-11-03 | 南阳师范学院 | 一种3‑(3,3‑二氯烯丙氧基)‑1‑甲基吡唑‑5‑甲酰胺衍生物及其制备方法 |
| RU2754180C2 (ru) | 2015-09-23 | 2021-08-30 | Новартис Аг | Соли и твердые формы монобактамного антибиотика |
| RU2746129C2 (ru) * | 2015-12-15 | 2021-04-07 | Мерк Шарп И Доум Корп. | Биарильные монобактамные соединения и способы их применения для лечения бактериальных инфекций |
| BR112018067930B1 (pt) * | 2016-03-07 | 2024-02-15 | Merck Sharp & Dohme Llc | Composto, sal de ácido trifluoroacético, composição farmacêutica, e, uso de um composto |
| CN107641119B (zh) | 2016-07-21 | 2019-11-08 | 中国科学院上海药物研究所 | 单环β-内酰胺-铁载体轭合物及其制备方法和用途 |
| WO2018038906A1 (en) | 2016-08-26 | 2018-03-01 | Codexis, Inc. | Engineered imine reductases and methods for the reductive amination of ketone and amine compounds |
| JP2019535722A (ja) | 2016-11-18 | 2019-12-12 | アイキュリス アンチ−インフェクティブ キュアズ ゲゼルシャフト ミット ベシュレンクテル ハフツング | 修飾シクロデキストリン及び酸性化剤に基づくアミジン置換ベータ−ラクタム化合物の新規製剤、それらの製造及び抗菌医薬組成物としての使用 |
| CA3043976A1 (en) | 2016-11-18 | 2018-05-24 | Aicuris Anti-Infective Cures Gmbh | Liposomal formulations of amidine substituted beta-lactam compounds for use in the treatment of bacterial infections |
| EA201991523A1 (ru) | 2016-12-21 | 2019-11-29 | Комбинированная терапия амидин-замещенными бета-лактамными соединениями и ингибиторами бета-лактамазы при инфекциях, вызванных бактериальными штаммами, резистентными к антибиотикам | |
| US20200181117A1 (en) | 2017-07-18 | 2020-06-11 | Bayer Cropscience Aktiengesellschaft | Substituted 3-heteroaryloxy-1h-pyrazoles and salts thereof and their use as herbicidal active substances |
| TW201920163A (zh) | 2017-07-28 | 2019-06-01 | 德商艾庫里斯抗感染治療有限公司 | (2s)‐2‐[[(z)‐[1‐(2‐胺基‐4‐噻唑基)‐2‐[[(3s)‐2,2‐二甲基‐4‐側氧基‐1‐(磺氧)‐3‐吖丁啶基]胺基]‐2‐氧亞乙基]胺基]氧基]‐3‐[4‐[亞胺基[(3r)‐3-哌啶基胺基]甲基]苯氧基]-丙酸之晶型 |
| WO2019026004A2 (en) | 2017-08-02 | 2019-02-07 | Novartis Ag | CHEMICAL PROCESS FOR THE PREPARATION OF ANTIBIOTIC MONOBACTAM AND ITS INTERMEDIATES |
| EP3691639B1 (en) | 2017-10-02 | 2023-11-15 | Merck Sharp & Dohme LLC | Chromane monobactam compounds for the treatment of bacterial infections |
| WO2019070595A1 (en) * | 2017-10-02 | 2019-04-11 | Arixa Pharmaceuticals, Inc. | AZTREONAM DERIVATIVES AND USES THEREOF |
| CN111511737B (zh) * | 2018-01-29 | 2022-10-18 | 南京明德新药研发有限公司 | 用于治疗细菌感染的单环β-内酰胺化合物 |
| US20220002288A1 (en) * | 2018-11-13 | 2022-01-06 | Nanjing Sanhome Pharmaceutical Co., Ltd. | Monobactam compounds and use therefor |
| JP7179185B2 (ja) | 2018-12-18 | 2022-11-28 | メッドシャイン ディスカバリー インコーポレイテッド | 医薬の製造おける単環式β－ラクタム化合物の使用 |
| CN111303144B (zh) * | 2019-12-13 | 2020-11-27 | 苏州信诺维医药科技有限公司 | 一种治疗细菌感染的化合物 |
| EP4079305A4 (en) | 2019-12-19 | 2024-01-10 | Shenzhen Optimum Biological Technology Co., Ltd | APPLICATION OF A COMPOUND IN THE PREPARATION OF DRUG |
| CN111253405B (zh) * | 2020-03-20 | 2022-12-16 | 南京安伦化工科技有限公司 | 一种比阿培南中间体的制备方法 |
| CN111592536B (zh) * | 2020-06-04 | 2023-11-03 | 宁夏农林科学院农业资源与环境研究所（宁夏土壤与植物营养重点实验室） | 单环β-内酰胺化合物及其制备方法和应用 |
| CN111675641B (zh) * | 2020-06-04 | 2023-09-08 | 宁夏农林科学院农业资源与环境研究所（宁夏土壤与植物营养重点实验室） | 单环β-内酰胺类化合物、单环内酰胺类化合物盐及其制备方法 |
| EP4165039B1 (en) * | 2020-07-16 | 2024-08-21 | Ningxia Academy of Agriculture and Forestry Sciences | Novel monobactam compounds, their preparation and use as antibacterial agents |
| WO2022027439A1 (en) * | 2020-08-06 | 2022-02-10 | Ningxia Academy Of Agriculture And Forestry Sciences | β-LACTAM COMPOUNDS, THEIR PREPARATION AND USE AS ANTIBACTERIAL AGENTS |
| CN112079791A (zh) * | 2020-08-21 | 2020-12-15 | 宁夏农林科学院农业资源与环境研究所（宁夏土壤与植物营养重点实验室） | 单环β-内酰胺类抗生素侧链酸及其酯、其制备方法和应用 |
| CN111909067B (zh) * | 2020-08-28 | 2022-03-15 | 浙江凯普化工有限公司 | 一种d-青霉胺的有机全合成方法 |
| AU2021473165A1 (en) * | 2021-11-09 | 2024-05-23 | Guangzhou HC New Drug Research Co., Ltd. | PHARMACEUTICAL COMPOSITION CONTAINING β-LACTAM COMPOUND AND USE THEREOF |
| IL312841A (en) | 2021-11-18 | 2024-07-01 | Merck Sharp & Dohme Llc | CHROMANE AMIDINE MONOBACTAM ANTIBIOTICS |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE794886A (fr) * | 1972-02-22 | 1973-08-02 | Pfizer | Acides 6-(alpha-(omega-guanidinoalcanoylamino)acylamino)-penicillaniques |
| DE2458973A1 (de) * | 1974-12-13 | 1976-06-16 | Hoechst Ag | Acylaminopenicillansaeuren und verfahren zu ihrer herstellung |
| DE2749265A1 (de) | 1977-11-03 | 1979-05-10 | Linde Ag | Verfahren zur biologischen reinigung von abwasser |
| ZA806977B (en) * | 1979-11-19 | 1981-10-28 | Fujisawa Pharmaceutical Co | 7-acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof |
| JPS58210061A (ja) * | 1982-05-31 | 1983-12-07 | Takeda Chem Ind Ltd | １−スルホ−２−オキソアゼチジン誘導体、その製造法および用途 |
| CA1262128A (en) | 1981-08-27 | 1989-10-03 | Christian N. Hubschwerlen | .beta.-lactams |
| NZ205642A (en) | 1982-10-06 | 1986-08-08 | Squibb & Sons Inc | Beta-lactams and pharmaceutical compositions |
| US4638060A (en) | 1985-04-29 | 1987-01-20 | E. R. Squibb & Sons, Inc. | O-sulfated spiro β-lactam hydroxamic acids |
| JPH01290674A (ja) | 1988-04-04 | 1989-11-22 | E R Squibb & Sons Inc | アゼチジニル誘導体 |
| US5112968A (en) | 1989-07-28 | 1992-05-12 | E. R. Squibb & Sons, Inc. | Monobactam hydrazide derivatives |
| CA2024282A1 (en) | 1989-09-21 | 1991-03-22 | Peter H. Ermann | Heterocyclic hydrazide derivatives of monocyclic beta-lactam antibiotics |
| ZA918014B (en) | 1990-11-05 | 1992-07-29 | Squibb & Sons Inc | Heteroaroyl derivatives of monocyclic beta-lactam antibiotics |
| US5250691A (en) | 1991-09-09 | 1993-10-05 | E. R. Squibb & Sons, Inc. | Heteroaryl derivatives of monocyclic beta-lactam antibiotics |
| US5994340A (en) | 1997-08-29 | 1999-11-30 | Synphar Laboratories, Inc. | Azetidinone derivatives as β-lactamase inhibitors |
| EP1322648B1 (en) | 2000-09-14 | 2005-06-29 | Pantherix Limited | 3-(heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents |
| WO2005070874A1 (en) | 2004-01-27 | 2005-08-04 | Merck Frosst Company | Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors |
| NZ567629A (en) | 2005-09-23 | 2011-08-26 | Ms Science Corp | Piperazine derivatives useful in the treatment of discorders of the central nervous system |
| CN103724330B (zh) * | 2005-12-07 | 2015-08-19 | 巴斯利尔药物股份公司 | 单环-内酰胺类抗生素与β-内酰胺酶抑制剂的有效的联合应用 |
| NZ570495A (en) | 2006-02-14 | 2011-10-28 | Ihara Chemical Ind Co | Process for production of 5-alkoxy-4-hydroxymethylpyrazole compound |
| US20090012054A1 (en) | 2006-03-16 | 2009-01-08 | Astellas Pharma Inc. | Cephem Compounds and Use as Antimicrobial Agents |
| CN101641095B (zh) | 2007-03-23 | 2012-10-31 | 巴斯利尔药物股份公司 | 用于治疗细菌感染的组合药物 |
| WO2009049028A1 (en) | 2007-10-09 | 2009-04-16 | Targegen Inc. | Pyrrolopyrimidine compounds and their use as janus kinase modulators |
| CN102325769A (zh) | 2008-12-19 | 2012-01-18 | 美国辉瑞有限公司 | 单卡波姆 |
-
2013
- 2013-01-22 UY UY0001034585A patent/UY34585A/es not_active Application Discontinuation
- 2013-01-23 CU CUP2014000090A patent/CU24273B1/es unknown
- 2013-01-23 WO PCT/EP2013/051217 patent/WO2013110643A1/en active Application Filing
- 2013-01-23 ME MEP-2016-191A patent/ME02532B/me unknown
- 2013-01-23 EA EA201400838A patent/EA027126B1/ru unknown
- 2013-01-23 SG SG11201403930XA patent/SG11201403930XA/en unknown
- 2013-01-23 UA UAA201409319A patent/UA110880C2/uk unknown
- 2013-01-23 IN IN1640MUN2014 patent/IN2014MN01640A/en unknown
- 2013-01-23 RS RS20160764A patent/RS55210B1/sr unknown
- 2013-01-23 PE PE2014001132A patent/PE20142345A1/es active IP Right Grant
- 2013-01-23 US US14/374,325 patent/US9556165B2/en active Active
- 2013-01-23 KR KR1020147020410A patent/KR102036393B1/ko active IP Right Grant
- 2013-01-23 DK DK13701246.4T patent/DK2806873T3/en active
- 2013-01-23 MY MYPI2014002088A patent/MY173843A/en unknown
- 2013-01-23 AP AP2014007880A patent/AP2014007880A0/xx unknown
- 2013-01-23 MX MX2014008915A patent/MX346602B/es active IP Right Grant
- 2013-01-23 NZ NZ626951A patent/NZ626951A/en not_active IP Right Cessation
- 2013-01-23 CA CA2862338A patent/CA2862338C/en not_active Expired - Fee Related
- 2013-01-23 BR BR112014017968A patent/BR112014017968A8/pt not_active Application Discontinuation
- 2013-01-23 PL PL13701246.4T patent/PL2806873T3/pl unknown
- 2013-01-23 ES ES13701246.4T patent/ES2592403T3/es active Active
- 2013-01-23 PT PT137012464T patent/PT2806873T/pt unknown
- 2013-01-23 TW TW102102410A patent/TWI659953B/zh not_active IP Right Cessation
- 2013-01-23 AU AU2013211575A patent/AU2013211575B2/en not_active Ceased
- 2013-01-23 HU HUE13701246A patent/HUE030452T2/en unknown
- 2013-01-23 CN CN201380016121.9A patent/CN104203237A/zh active Pending
- 2013-01-23 LT LTEP13701246.4T patent/LT2806873T/lt unknown
- 2013-01-23 EP EP13701246.4A patent/EP2806873B1/en active Active
- 2013-01-23 SI SI201330299A patent/SI2806873T1/sl unknown
- 2013-01-23 JP JP2014553696A patent/JP5869701B2/ja not_active Expired - Fee Related
- 2013-01-24 AR ARP130100215A patent/AR089796A1/es unknown
-
2014
- 2014-07-08 TN TNP2014000297A patent/TN2014000297A1/fr unknown
- 2014-07-10 ZA ZA2014/05057A patent/ZA201405057B/en unknown
- 2014-07-22 CO CO14158608A patent/CO7101240A2/es unknown
- 2014-07-22 EC ECIEPI201410249A patent/ECSP14010249A/es unknown
- 2014-07-22 PH PH12014501671A patent/PH12014501671B1/en unknown
- 2014-07-24 IL IL233805A patent/IL233805A/en active IP Right Grant
- 2014-07-24 CL CL2014001956A patent/CL2014001956A1/es unknown
- 2014-08-08 MA MA37280A patent/MA35905B1/fr unknown
-
2015
- 2015-04-24 HK HK15104018.3A patent/HK1203389A1/zh not_active IP Right Cessation
-
2016
- 2016-08-30 CY CY20161100851T patent/CY1117955T1/el unknown
- 2016-09-13 HR HRP20161171TT patent/HRP20161171T1/hr unknown
- 2016-10-06 SM SM201600354T patent/SMT201600354B/it unknown
- 2016-12-19 US US15/382,986 patent/US9782390B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL233805A (en) | Beta-lactam compounds are amidin-conserved, produced and used as an anti-bacterial substance | |
| ZA201408803B (en) | Substituted pyrazole-containing compounds and their use as pesticides | |
| EP2931723A4 (en) | NEW BICYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND LACTAMASE INHIBITORS | |
| HK1206031A1 (en) | Antibacterial compounds | |
| EP2761029A4 (en) | NOVEL BACTERIOPHAGE AND ANTIBACTERIAL COMPOSITION THEREWITH | |
| IL237035B (en) | Antibacterial compound for external use | |
| HK1212156A1 (en) | Antimicrobial composition | |
| HK1206348A1 (en) | Cyclohexane-1,2-indene-1,2-imidazol compounds and their use as bace inhibitors -12--12- bace | |
| HK1215031A1 (zh) | 抗微生物劑 | |
| EP2922843A4 (en) | INDOLE COMPOUNDS AND THEIR USE AS ANTIMICROBIALS | |
| EP2903979A4 (en) | Novel compounds, their preparation and use | |
| EP2757092A4 (en) | SUBSTITUTED CYANANILIN COMPOUNDS, METHOD OF MANUFACTURING THEREOF AND USE THEREOF | |
| EP2913325A4 (en) | SUBSTITUTED PYRIMIDINE COMPOUND AND APPLICATIONS THEREOF | |
| HK1212677A1 (zh) | 新型抗細菌化合物 | |
| SI2833929T1 (sl) | Antimikrobna obveza | |
| ZA201501641B (en) | Phenicol antibacterial agents | |
| HK1210954A1 (en) | Antibacterial compounds | |
| ZA201408903B (en) | Antimicrobial composition | |
| GB201211202D0 (en) | Antimicrobial compounds | |
| IL239207A0 (en) | Antibacterial compounds | |
| EP2875141A4 (en) | ANTIMICROBIAL ACTIVE SUBSTANCES | |
| AU2012903369A0 (en) | Antibacterial Agent | |
| AU2011900316A0 (en) | Metallocomplexes and their use as antibacterial agents | |
| GB201211203D0 (en) | Antimicrobial compounds |